article thumbnail

Medicare Drug Cuts Target CVD Meds, Drive Debates

CardiacWire

Medicare drug price negotiations are one of the highlighted results of 2022’s Inflation Reduction Act, allowing CMS to negotiate drug prices for the very first time. Between 2026 and 2029, CMS will select 60 targeted meds based on a range of factors (costs, usage, “single-source,” lack of generics, etc.)

article thumbnail

The Evolving Computed Tomography Market

DAIC

Data was pulled from 2010–2019 Physician/Supplier Procedure Summary (PSPS) files obtained from the Centers for Medicare and Medicaid Services (CMS) website. According to the company, the Duo system adds high resolution thoracic clinical capability, suitable for screening lung cancer, COVID-19 and other pulmonary diseases.